Cargando…
Rates and risk of arrhythmias in cancer survivors with chemotherapy-induced cardiomyopathy compared with patients with other cardiomyopathies
OBJECTIVES: There is little information about arrhythmia burden in cancer survivors with chemotherapy-induced cardiomyopathy (CIC). We hypothesise that the rates and risk of arrhythmias will be similar in CIC when compared with other non-ischaemic cardiomyopathy (NICMO) aetiologies. METHODS: We retr...
Autores principales: | Fradley, Michael G, Viganego, Federico, Kip, Kevin, Martin, Angel, Patel, Aarti A, Ismail-Khan, Roohi, Chae, Sanders, Herweg, Bengt, Labovitz, Arthur |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761288/ https://www.ncbi.nlm.nih.gov/pubmed/29344369 http://dx.doi.org/10.1136/openhrt-2017-000701 |
Ejemplares similares
-
Study of indications for cardiac device implantation and utilisation in Fabry cardiomyopathy
por: Vijapurapu, Ravi, et al.
Publicado: (2019) -
Predictors of risk for sudden death in childhood hypertrophic cardiomyopathy: the importance of the ECG risk score
por: Östman-Smith, Ingegerd, et al.
Publicado: (2017) -
Lifestyle physical activity and rapid-rate non-sustained ventricular tachycardia in arrhythmogenic cardiomyopathy
por: Ramos-Maqueda, Javier, et al.
Publicado: (2023) -
Myocardial scar burden predicts survival benefit with implantable cardioverter defibrillator implantation in patients with severe ischaemic cardiomyopathy: influence of gender
por: Kwon, Deborah H, et al.
Publicado: (2014) -
Prospective arrhythmia surveillance after a COVID-19 diagnosis
por: Dewland, Thomas A, et al.
Publicado: (2022)